| Product Code: ETC7267024 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Gambia Molecular Point of Care Testing (using NAAT) Market Overview |
3.1 Gambia Country Macro Economic Indicators |
3.2 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, 2021 & 2031F |
3.3 Gambia Molecular Point of Care Testing (using NAAT) Market - Industry Life Cycle |
3.4 Gambia Molecular Point of Care Testing (using NAAT) Market - Porter's Five Forces |
3.5 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Gambia Molecular Point of Care Testing (using NAAT) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in The Gambia |
4.2.2 Rising demand for rapid and accurate diagnostic solutions |
4.2.3 Government initiatives to improve healthcare infrastructure and services |
4.3 Market Restraints |
4.3.1 High cost associated with molecular point of care testing (using NAAT) |
4.3.2 Limited access to advanced healthcare facilities in remote areas of The Gambia |
4.3.3 Lack of skilled healthcare professionals proficient in molecular testing techniques |
5 Gambia Molecular Point of Care Testing (using NAAT) Market Trends |
6 Gambia Molecular Point of Care Testing (using NAAT) Market, By Types |
6.1 Gambia Molecular Point of Care Testing (using NAAT) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 Gambia Molecular Point of Care Testing (using NAAT) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Respiratory Infections Testing, 2021- 2031F |
6.2.3 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Sexually Transmitted Infection (STI) Testing, 2021- 2031F |
6.2.4 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Gastrointestinal Tract Infections Testing, 2021- 2031F |
6.2.5 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Gambia Molecular Point of Care Testing (using NAAT) Market, By End users |
6.3.1 Overview and Analysis |
6.3.2 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.5 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Ambulatory Centers, 2021- 2031F |
6.3.6 Gambia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
7 Gambia Molecular Point of Care Testing (using NAAT) Market Import-Export Trade Statistics |
7.1 Gambia Molecular Point of Care Testing (using NAAT) Market Export to Major Countries |
7.2 Gambia Molecular Point of Care Testing (using NAAT) Market Imports from Major Countries |
8 Gambia Molecular Point of Care Testing (using NAAT) Market Key Performance Indicators |
8.1 Time-to-diagnosis for infectious diseases |
8.2 Number of healthcare facilities equipped with molecular point of care testing capabilities |
8.3 Percentage increase in the adoption of molecular point of care testing technologies |
8.4 Average turnaround time for test results |
8.5 Rate of successful treatment outcomes attributed to molecular point of care testing |
9 Gambia Molecular Point of Care Testing (using NAAT) Market - Opportunity Assessment |
9.1 Gambia Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Gambia Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Gambia Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Gambia Molecular Point of Care Testing (using NAAT) Market - Competitive Landscape |
10.1 Gambia Molecular Point of Care Testing (using NAAT) Market Revenue Share, By Companies, 2024 |
10.2 Gambia Molecular Point of Care Testing (using NAAT) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here